Clinical trial
Transcriptome-based Diagnostic Biomarker for Acute Febrile Illness: a Cross-sectional Observational Study
NCT06552975 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcriptome-based Diagnostic Biomarker for Acute Febrile Illness: a Cross-sectional Observational Study
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2021
- Completion date
- August 30, 2025
- Enrollment
- 900 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute febrile illness